DE19852435C2 - Medicines (trace element preparation) for detoxifying the body from mercury from amalgam dental fillings - Google Patents
Medicines (trace element preparation) for detoxifying the body from mercury from amalgam dental fillingsInfo
- Publication number
- DE19852435C2 DE19852435C2 DE19852435A DE19852435A DE19852435C2 DE 19852435 C2 DE19852435 C2 DE 19852435C2 DE 19852435 A DE19852435 A DE 19852435A DE 19852435 A DE19852435 A DE 19852435A DE 19852435 C2 DE19852435 C2 DE 19852435C2
- Authority
- DE
- Germany
- Prior art keywords
- mercury
- detoxifying
- dollar
- selenium
- side effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Die Erfindung betrifft ein Arzneimittel zur Entgiftung des Körpers von Quecksilber aus Amalgam-Zahnfüllungen. DOLLAR A Es besteht das Bedürfnis nach weiteren zur Behandlung von Quecksilberbelastungen geeigneten Arzneimitteln, die möglichst wenig Nebenwirkungen haben und somit auch für eine Langzeittherapie geeignet sind. DOLLAR A Erfindungsgemäß wird ein Spurenelementpräparat zur Entgiftung des Körpers vorgeschlagen, das dadurch gekennzeichnet ist, daß es einen Gehalt von Selen und Germanium in einer vom Körper optimal verwertbaren Form gleichzeitig enthält. DOLLAR A Die Herstellung des erfindungsgemäßen Arzneimittels erfolgt in ausgewogener Zusammensetzung; eine Tablette enthält: Selen 0,03 mg, Germanium 1,84 mg. DOLLAR A Das erfindungsgemäße Arzneimittel ist ausgezeichnet verträglich und zeichnet sich dadurch aus, daß selbst bei empfindlich reagierenden Patienten auch bei einer Langzeittherapie keine Nebenwirkungen auftreten und in der Regel auf die zusätzliche Einnahme von Chelatbildner mit oft ernsthaften Nebenwirkungen verzichtet werden kann.The invention relates to a medicament for detoxifying the body of mercury from amalgam tooth fillings. DOLLAR A There is a need for other drugs suitable for the treatment of mercury pollution, which have as few side effects as possible and are therefore also suitable for long-term therapy. DOLLAR A According to the invention, a trace element preparation for detoxifying the body is proposed, which is characterized in that it simultaneously contains a content of selenium and germanium in a form which can be optimally used by the body. DOLLAR A The pharmaceutical composition according to the invention is produced in a balanced composition; one tablet contains: selenium 0.03 mg, germanium 1.84 mg. DOLLAR A The medicament according to the invention is excellently tolerated and is distinguished by the fact that even with long-term therapy there are no side effects, even in the case of sensitive patients, and it is generally possible to dispense with the additional intake of chelating agents with often serious side effects.
Description
Die Erfindung betrifft ein Arzneimittel (Spurenelementpräparat) zur Ent giftung des Körpers von Quecksilber aus Amalgan-Zahnfüllungen.The invention relates to a medicament (trace element preparation) for ent Poisoning the body of mercury from amalgan fillings.
Es besteht das Bedürfnis nach weiteren zur Behandlung von Quecksilber belastungen geeigneten Arzneimitteln, die möglichst wenig Nebenwir kungen haben und somit auch für eine Langzeittherapie geeignet sind.There is a need for others to treat mercury suitable drugs that have as few side effects as possible have kung and are therefore also suitable for long-term therapy.
Aus der US 4859453 A ist eine entgiltende Wirkung von Selen gegenüber Quecksilber bekannt, aus der US 5205743A ein Verfahren zu Absorption von Qucksilberdämpfen durch Selen-haltige Filter.From US 4859453 A is a detoxifying effect of selenium Mercury is known from US 5205743A a method for absorption of mercury vapors through selenium-containing filters.
Erfindungsgemäß wird ein Spurenelementpräparat zur Entgilftung des Körpers vorgeschlagen, das dadurch gekennzeichnet ist, daß es einen Gehalt von Selen und Germanium in einer vom Körper optimal verwert baren Form gleichzeitig enthält, wobei eine Tablette jeweils Selen 0,03 mg und Germanium 1,84 mg enthält. Das erfindungsgemäße Arznei mittel ist ausgezeichnet verträglich und zeichnet sich dadurch aus, daß selbst bei empfindlich reagierenden Patienten auch bei einer Langzeit therapie keine Nebenwirkungen auftreten und in der Regel auf die zu sätzliche Einnahme von Chelatbildner mit oft ernsthaften Nebenwir kungen verzichtet werden kann.According to the invention, a trace element preparation for the detoxification of the Body proposed, which is characterized in that it is a Selenium and germanium content optimally utilized by the body baren form at the same time, one tablet each selenium 0.03 mg and germanium contains 1.84 mg. The medicament according to the invention medium is extremely well tolerated and is characterized by the fact that even with sensitive patients even with a long-term Therapy no side effects occur and usually on the too additional intake of chelating agent with often serious side effects can be dispensed with.
Die Herstellung des erfindungsgemäßen Arzneimittels erfolgt in einer vom Körper optimal verwertbaren Form; eine Tablette enthält 0,03 mg Selen und 1,84 mg Germanium.The medicament according to the invention is produced in one optimally usable form by the body; one tablet contains 0.03 mg Selenium and 1.84 mg germanium.
Das Arzneimittel wird in einer ausgewogenen Zusammensetzung herge stellt.The drug is produced in a balanced composition poses.
1 Tablette enthält: Selen 0,03 mg, Germanium 1,84 mg.1 tablet contains: selenium 0.03 mg, germanium 1.84 mg.
Selen und Germanium liegen als Aminosäure-Chelate vor.Selenium and germanium are present as amino acid chelates.
Patienten mit Quecksilberbelastungen verschiedener Genese, die zum Teil belastende Nebenwirkungen bei der Therapie mit bekannten Che latbildner hatten, erhielten täglich zu drei Mahlzeiten je 1 Tablette mit 1 Glas Wasser des nach Beispiel 1 hergestellten Arzneimittels.Patients with mercury pollution of various origins Partly stressful side effects in therapy with known Che had latformers, received 1 tablet each with three meals 1 glass of water of the drug prepared according to Example 1.
Bereits nach einer Behandlungszeit von nur 4 Tagen meldeten die meist en Patienten subjektive Besserung; insbesondere wurden auch bei einer mehrmonatigen Medikation keine Nebenwirkungen oder Unverträglich keit beobachtet.Most reported after only 4 days of treatment en patient subjective improvement; in particular were also at one Medication lasting several months no side effects or intolerance observed.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19852435A DE19852435C2 (en) | 1997-11-13 | 1998-05-23 | Medicines (trace element preparation) for detoxifying the body from mercury from amalgam dental fillings |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19750287A DE19750287A1 (en) | 1997-11-13 | 1997-11-13 | Homeopathic remedy to detoxify the body from mercury, |
| DE19852435A DE19852435C2 (en) | 1997-11-13 | 1998-05-23 | Medicines (trace element preparation) for detoxifying the body from mercury from amalgam dental fillings |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE19852435A1 DE19852435A1 (en) | 1999-09-09 |
| DE19852435C2 true DE19852435C2 (en) | 2000-01-05 |
Family
ID=7848604
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19750287A Withdrawn DE19750287A1 (en) | 1997-11-13 | 1997-11-13 | Homeopathic remedy to detoxify the body from mercury, |
| DE19852435A Expired - Fee Related DE19852435C2 (en) | 1997-11-13 | 1998-05-23 | Medicines (trace element preparation) for detoxifying the body from mercury from amalgam dental fillings |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19750287A Withdrawn DE19750287A1 (en) | 1997-11-13 | 1997-11-13 | Homeopathic remedy to detoxify the body from mercury, |
Country Status (1)
| Country | Link |
|---|---|
| DE (2) | DE19750287A1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4859453A (en) * | 1987-01-16 | 1989-08-22 | Sigvard Andheden | Method for preventing mercury poisoning caused by dissolution of mercury from amalgam fillings |
| US5205743A (en) * | 1991-02-07 | 1993-04-27 | Boliden Contech Ab | Dental treatment method |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2698870B2 (en) * | 1987-10-29 | 1998-01-19 | 株式会社浅井ゲルマニウム研究所 | Agent for reducing nephrotoxicity by administration of cyclosporine |
-
1997
- 1997-11-13 DE DE19750287A patent/DE19750287A1/en not_active Withdrawn
-
1998
- 1998-05-23 DE DE19852435A patent/DE19852435C2/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4859453A (en) * | 1987-01-16 | 1989-08-22 | Sigvard Andheden | Method for preventing mercury poisoning caused by dissolution of mercury from amalgam fillings |
| US5205743A (en) * | 1991-02-07 | 1993-04-27 | Boliden Contech Ab | Dental treatment method |
Also Published As
| Publication number | Publication date |
|---|---|
| DE19750287A1 (en) | 1998-04-02 |
| DE19852435A1 (en) | 1999-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3435040A1 (en) | PHARMACEUTICAL COMPOSITION SUITABLE FOR TREATING HANG OVER SYMPTOMS | |
| EP0365571A1 (en) | Drug to treat the eye and suitable carrier material | |
| DE3705151A1 (en) | WARTS | |
| Epstein et al. | A clinical trial of bethanechol in patients with xerostomia after radiation therapy: a pilot study | |
| DE1902227A1 (en) | Medicines for psychotherapeutic use and processes for their manufacture | |
| EP1037648A2 (en) | The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases | |
| DE3348163C2 (en) | ||
| EP0037488B1 (en) | Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes | |
| DE60009145T3 (en) | COMPOSITION OF GINSENG AND GINKGO FOR THE IMPROVEMENT OF COGNITIVE PROPERTIES | |
| DE19852435C2 (en) | Medicines (trace element preparation) for detoxifying the body from mercury from amalgam dental fillings | |
| DE3500670A1 (en) | MEDICINAL PRODUCTS CONTAINING DIPHOSPHONATES | |
| EP0331014A2 (en) | Use of ACE inhibitors in diabetes prophylaxis | |
| DE3619426A1 (en) | AGENT FOR INCREASING RESISTANCE TO COLD DISEASES IN PATIENTS WITH RESTRICTED LUNG FUNCTION | |
| DE1917283C3 (en) | Manufacture of antimicrobial preparations | |
| DE60133284T2 (en) | MEDICAL COMBINATION PREPARATION FOR THE TREATMENT OF INJURED ABNORMAL TISSUE | |
| EP0402208B1 (en) | Mixture of Vitamin A in physiological dosis and different active ingredients having therapeutic effect | |
| DE2657382A1 (en) | ORAL ANTIDIABETIC | |
| DE69214979T2 (en) | New, dietary preparations based on phosphorus-lipid complexes and their use in sleep disorders | |
| DE3801900A1 (en) | Use of terpene-containing essential oils for controlling Aids and Arc, and pharmaceutical compositions containing them | |
| DE2015877A1 (en) | drug | |
| DE2352618A1 (en) | MEDICINAL PRODUCTS FOR THE TREATMENT OF PARKINSONISM | |
| DE10238161A1 (en) | Mucosal or topical administration of minerals, e.g. for treating muscle spasms, psoriasis or osteoporosis or promoting wound healing, comprises direct application of mineral solution from ampoule | |
| DE2038827C3 (en) | Oral and dental care products for the prevention and improvement of gingivitis and for treating periodontal disease | |
| EP0291751B1 (en) | Pharmaceutical mixture preparation | |
| DE3447572A1 (en) | Composition for regenerating and strengthening animal and human organisms and the body's own defences and the skin, and for the protection thereof, composed of aloe active substances |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |